<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-63348</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">Introduction and objectives. The aims were to determine the effectiveness of blood pressure (BP) control in hypertensive patients with left ventricular hypertrophy (LVH), as detected by ECG, and to identify the variables associated with poor control, particularly in diabetics. Methods. The study included hypertensive patients with ECG evidence of LVH who attended cardiology outpatient clinics between April 2003 and November 2004. Patient characteristics and clinical variables were recorded on admission to the study. Results. Of the 16,123 patients included, 4037 (25.04%) had LVH at presentation. Some 58.1% of these latter patients had a history of cardiovascular disease. Only 8.1% of diabetic patients had BP values below 130/80 mmHg, whereas 22.4% of nondiabetic patients were well-controlled. Multivariate analysis showed that the only independent predictors of poor BP control were diabetes (odds ratio [OR] 3.62, 95% confidence interval [CI] 2.7­4.7), female sex (OR 1.18, 95% CI 1.02­1.33), increased voltage recording in lead V5 (OR 1.027 per mm, 95% CI 1.01­1.03), and body mass index (OR 1.03, 95% CI 1.00­1.05), whereas a history of cardiovascular disease was associated with good BP control (OR 0.57, 95% CI 0.48­0.70). Conclusions. The prevalence of LVH, as identified by ECG, was high in hypertensive patients attending cardiology outpatient clinics, and comorbid conditions were common. Control of BP was suboptimal, particularly in diabetic patients, fewer than 10% of whom were well-controlled. Finally, BP control in patients with LVH was influenced by sex, body mass index, and a history of cardiovascular disease (AU)</dc:description>
<dc:creator>Fácila, Lorenzo</dc:creator>
<dc:creator>González-Juanatey, José R</dc:creator>
<dc:creator>Cea-Calvo, Luis</dc:creator>
<dc:creator>Aznar, Joaquin</dc:creator>
<dc:creator>Bertomeu, Vicente</dc:creator>
<dc:creator>Bertomeu González, Vicente</dc:creator>
<dc:creator>Mazón, Pilar</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción y objetivos. Evaluar el grado de control de cifras de presión arterial (PA) en hipertensos con hipertrofia ventricular izquierda (HVI) definida por el electrocardiograma y detectar las variables que se asocian a mal control, principalmente en diabéticos. Métodos. Desde abril de 2003 hasta noviembre de 2004 se incluyó a los hipertensos vistos en consultas de cardiología con criterios electrocardiográficos de HVI. Se determinaron las distintas variables en el momento de la inclusión. Resultados. Se incluyó a 16.123 pacientes, de los que 4.037 ya presentaron HVI (25,04%). El 58,1% de éstos tenían antecedentes de enfermedad cardiovascular. Sólo el 8,1% de los pacientes diabéticos presentó cifras de PA sistólica y diastólica &lt; 130 y 80 mmHg respectivamente, mientras que el 22,4% de los no diabéticos estaban controlados. En el análisis multivariable, los predictores de mal control fueron la diabetes (odds ratio [OR] = 3,62; intervalo, 2,7-4,7), el sexo femenino (OR = 1,18; 1,02-1,33), el voltaje aumentado de la derivación V5 (por cada milímetro, OR = 1,027; 1,01-1,03) y el índice de masa corporal (IMC) (OR = 1,03; 1,00-1,05); el antecedente de enfermedad cardiovascular se comportó como un factor asociado a buen control (OR = 0,57; 0,48-0,70). Conclusiones. Los hipertensos atendidos en consultas de cardiología presentan una alta prevalencia de HVI detectada por el electrocardiograma y una gran comorbilidad. El control de las cifras de PA es subóptimo, en especial en pacientes diabéticos, en quienes no alcanza el 10%. Por último, el control de los valores de PA en pacientes con HVI depende, además, del sexo, el IMC y los antecedentes (AU)</dc:description>
<dc:source>Rev Esp Cardiol;60(12): 1257-1263, dic. 2007. ilus, tab</dc:source>
<dc:identifier>ibc-63348</dc:identifier>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d1822^s22074</dc:subject>
<dc:subject>^d30693^s22032</dc:subject>
<dc:subject>^d7152^s22016</dc:subject>
<dc:subject>^d23802</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d30693^s22080</dc:subject>
<dc:type>article</dc:type>
<dc:date>200712</dc:date>
</metadata>
</record>
</ibecs-document>
